Close Menu

NEW YORK (360Dx) – The US Food and Drug Administration has cleared Accelerate Diagnostics' test kit and instrument platform for identifying organisms that cause bloodstream infections, the company said late Thursday.

The kit also provides information about antibiotic sensitivity, and with the clearance Accelerate can market the test and platform in the US.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.